Zoetis (ZTS) Non-Current Debt (2013 - 2026)
Zoetis (ZTS) reported Non-Current Debt of $9.0 billion for Q1 2026, up 73.04% year-over-year from $5.2 billion in Q1 2025, and little changed quarter-over-quarter from $9.0 billion in Q4 2025.
Zoetis (ZTS) Non-Current Debt (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has 14 years of Non-Current Debt data on file, last reported at $9.0 billion in Q1 2026.
- Non-Current Debt for Q1 2026 came in at $9.0 billion, up 73.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.0 billion (up 73.04% YoY), and the FY2025 annual result was $9.0 billion, up 73.22% from the prior year.
- Non-Current Debt held at $9.0 billion in Q1 2026 per ZTS's latest filing, from $9.0 billion in the prior quarter.
- Over five years, Non-Current Debt peaked at $9.0 billion in Q1 2026 and troughed at $5.2 billion in Q3 2022.
- A 5-year average of $6.4 billion and a median of $6.6 billion in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2025: Non-Current Debt dropped 20.96% in 2022, then surged 73.22% in 2025.
- A 5-year view of Non-Current Debt shows it stood at $6.6 billion in 2022, then increased by 0.18% to $6.6 billion in 2023, then fell by 20.48% to $5.2 billion in 2024, then surged by 73.22% to $9.0 billion in 2025, then advanced by 0.03% to $9.0 billion in 2026.
- Business Quant data shows ZTS's Non-Current Debt at $9.0 billion in Q1 2026, $9.0 billion in Q4 2025, and $7.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 569.60 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.05 Bn |
| Mar 31, 2026 | 9.05 Bn |
| Dec 31, 2025 | 9.04 Bn |
| Dec 31, 2025 | 9.04 Bn |
| Sep 30, 2025 | 7.07 Bn |
| Sep 30, 2025 | 7.07 Bn |
| Jun 30, 2025 | 5.23 Bn |
| Jun 30, 2025 | 5.23 Bn |
| Mar 31, 2025 | 5.23 Bn |
| Mar 31, 2025 | 5.23 Bn |
| Dec 31, 2024 | 5.22 Bn |
| Dec 31, 2024 | 5.22 Bn |
| Sep 30, 2024 | 6.57 Bn |
| Sep 30, 2024 | 6.57 Bn |
| Jun 30, 2024 | 6.56 Bn |
| Jun 30, 2024 | 6.56 Bn |
| Mar 31, 2024 | 6.56 Bn |
| Mar 31, 2024 | 6.56 Bn |
| Dec 31, 2023 | 6.56 Bn |
| Dec 31, 2023 | 6.56 Bn |